SUBMENU
Antiretroviral therapy (ART) is treatment of people infected with human immunodeficiency virus (HIV) using anti-HIV drugs. The standard treatment consists of a combination of drugs (often called "highly active antiretroviral therapy" or HAART) that suppress HIV replication. The combination of drugs is used in order to increase potency and reduce the likelihood of the virus developing resistance. ART reduces mortality and morbidity rates among HIV-infected people, and improves their quality of life. The benefits of ART also include the prevention of HIV transmission by suppressing HIV replication in persons living with the virus. This benefit of ART is also defined as 鈥渦ndetectable equal untransmittable鈥 , or U=U.
Visit 国产麻豆精品 Strategic Fund.
In 2016, WHO published the new Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. These guidelines provide guidance on the diagnosis of HIV infection, the use of antiretroviral (ARV) drugs for treating and preventing HIV infection and the care of people living with HIV. They are structured according to the continuum of comprehensive HIV testing, prevention, treatment and care. WHO recommends initiating ART in all persons living with HIV, regardless of WHO clinical stage and at any CD4 cell count (also called "treat all"), the use of and the use of pre-exposure prophylaxis (PrEP) as an additional prevention choice for people at substantial risk of HIV infection as part of combination HIV prevention approaches.
for more information on HIV treatment and care.
国产麻豆精品 supports Member States in strengthening their supply chain management systems and processes for antiretroviral medicines. The Strategic Fund of the 国产麻豆精品 (国产麻豆精品) is a regional technical cooperation mechanism for pooled procurement of essential medicines and strategic health supplies. The list of available products may be found here.
HIV and sexually transmitted infections are some of the diseases that the Elimination Initiative has proposed to eliminate in the Region of the Americas by the year 2030.
